MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-022-03433-6

Медицинская библиотека · International journal of hematology · 2022

Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.

Tsuda Mariko, Hirata Akie, Tokunaga Shoji, Masuda Toru, Haji Shojiro, Kimura Daisaku, Nojiri Chinatsu, Nakashima Yasuhiro, Shiratsuchi Motoaki, Kato Koji, Miyamoto Toshihiro, Akashi Koichi, Nakashima Naoki, Ogawa Yoshihiro

СтатьяПеревод пока не подготовлен

Аннотация

Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML). However, TKI-related chronic renal toxicity has been reported, particularly in patients with hypertension. We assessed whether incidental use of specific types of antihypertensive drugs, including renin-aldosterone-angiotensin system inhibitors (RAASis), affects the change in estimated glomerular filtration rate (eGFR) during TKI treatment. We retrospectively analyzed all eGFR measurements during TKI treatment for 142 CML patients at Kyushu University Hospital, estimating the rate of eGFR change using a mixed-effects model. Overall, a significant interaction was found between the type of antihypertensive medication used and the yearly change in eGFR (P < 0.01), with RAASi users exhibiting the most rapid decrease in eGFR (- 5.5%/year). The analysis by TKI used showed that the interaction was significant only in imatinib and bosutinib users (P < 0.01 and P = 0.04, respectively). The yearly rate of eGFR decrease was the most notable in RAASi users, at - 5.7 (- 6.6, - 4.9) and - 10.1 (- 12.3, - 7.9) for imatinib and bosutinib users, respectively. Our findings indicate that eGFR should be carefully monitored in patients taking these TKIs.

Для цитирования: Tsuda Mariko, Hirata Akie, Tokunaga Shoji, Masuda Toru, Haji Shojiro, Kimura Daisaku, Nojiri Chinatsu, Nakashima Yasuhiro, Shiratsuchi Motoaki, Kato Koji, Miyamoto Toshihiro, Akashi Koichi, Nakashima Naoki, Ogawa Yoshihiro. Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.. International journal of hematology. 2022. DOI: 10.1007/s12185-022-03433-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.